See also >> video and audio clips of interviews

STAT News

As controversial decisions mount, FDA shuns public advisory meetings [PDF] (March 9, 2026)

by Lizzy Lawrence

Regulatory Focus

Experts argue recent FDA expert panels may violate FACA requirements (February 17, 2026)

by Jeff Craven

PharmaVoice

Politicization runs deeper than ever at FDA, risking long-term impacts (January 29, 2026)

by Michael Gibney

MedPage Today

Five leaders in one year: FDA’s drug center enters 2026 at a crossroads [PDF] (December 30, 2025)

by Joedy McCreary

BMJ News

Will the new FDA fix the old FDA? [PDF] (November 21, 2025)

by Jeanne Lenzer and Shannon Brownlee

STAT News

As medical AI use grows, industry payments to providers remain opaque [PDF] (September 22, 2025)

by Katie Palmer

Politico

Industry payments shape doctor decisions (September 18, 2025)

by Ruth Reader

Science

NIH promises to create conflict-of-interest database for scientists, but offers few details [PDF] (September 17, 2025)

by Phie Jacobs

CNN

Five new members named to influential CDC vaccine advisory committee days ahead of key meeting (September 15, 2025)

by Katherine Dillinger and Brenda Goodman

KFF Health News

Under Trump, FDA seeks to abandon expert reviews of new drugs (September 12, 2025)

by Arthur Allen

New York Times

Kennedy, rejecting data, fuels distrust of his own agencies [PDF] (September 7, 2025)

by Sheryl Gay Stolberg

CNN

RFK Jr set to add new members to influential CDC vaccine advisory panel (September 5, 2025)

by Brenda Goodman

STAT News

Kennedy faces off with senators, defends hiring CDC director at hearing [PDF] (September 4, 2025)

by Chelsea Cirruzzo, Daniel Payne, Isabella Cueto, Lev Facher, and Matthew Herper

New York Times

Covid vaccine opponent tapped to lead federal review team [PDF] (August 22, 2025)

by Christina Jewett

CNBC

New study casts doubts on RFK Jr’s reasons for gutting key vaccine panel (August 19, 2025)

by Annika Kim Constantino

Reuters

Vaccine panel fired by Kennedy had lowest rate of financial conflicts since 2000, study shows (August 19, 2025)

by Nancy Lapid

BioSpace

Conflicts of interest in vaccine committees have been plunging for decades (August 19, 2025)

by Dan Samorodnitsky

NBC

Conflicts on vaccine panels were at record lows before Kennedy’s firings (August 18, 2025)

by Berkeley Lovelace Jr

Bloomberg

Vaccine panel conflicts hit record law before RFK Jr headed HHS (August 18, 2025)

by Jessica Nix

MedPage Today

Are vaccine panels at CDC, FDA ‘plagued’ by conflicts? Numbers say no (August 18, 2025)

by Terrence Rudd

STAT News

Conflicts among CDC and FDA vaccine panel members are not as numerous as you think, study finds [PDF] (August 18, 2025)

by Ed Silverman

AP

FDA’s new expert panels are rife with financial conflicts and fringe views (August 18, 2025)

by Matthew Perrone

MedPage Today

New FDA drug chief: ‘revolving door’ or reformer? (July 28, 2025)

by Joedy McCreary

Bloomberg Law

FDA’s drug chief pick at odds with RFK Jr’s revolving door vow [PDF] (July 25, 2025)

by Nyah Phengsitthy

STAT News

FDA chief’s goals of ‘radical transparency’ threatened by agency cuts [PDF] (June 23, 2025)

by Lizzy Lawrence

Reuters

Kennedy’s ouster of US vaccine advisors puts pharma ties under scrutiny (June 12, 2025)

by Chad Terhune

PricePod podcast (Audio)

Closing the revolving door (June 4, 2025)

Interview with Christian Hetrick

Cincinnati Enquirer

Nearly 60% of doctors take money from Big Pharma. Is your doctor one? [PDF] (May 18, 2025)

by Elizabeth B. Kim

BioSpace

Banning industry from FDA adcomms won’t ‘move the needle much’ in Makary, RFK’s fight against COIs (April 21, 2025)

by Heather McKenzie

BioSpace

FDA after the storm: drug review delays and increased executive oversight expected (April 14, 2025)

by Heather McKenzie

BioSpace

FDA job cuts, key departures bring ‘revolving door’ debate front and center (April 2, 2025)

by Heather McKenzie

CNBC

US health department plans to slash 10,000 jobs as RFK Jr upends agencies (March 27, 2025)

by Annika Kim Constantino

Newsmax: America Right Now (Video)

Trump 2.0: Department of Health and Human Services [video interview starts @ 00:40] (March 1, 2025)

Interview with Tom Basile

STAT News

Trump’s pick to run FDA is top exec of company that provides compounded weight-loss drugs (paywall) [PDF] (November 24, 2024)

by John Wilkerson, Rachel Cohrs Zhang, and Katie Palmer

CNBC

RFK Jr is Trump’s pick to lead HHS — here’s what he could do with that power (November 19, 2024)

by Annika Kim Constantino

CNBC

Trump says he will give RJK Jr a major health role if he wins the White House. Here’s what that means for patients, drugmakers (November 5, 2024)

by Annika Kim Constantino

Wired

RFK Jr. wants to reshape US health policy. Good luck with that (October 31, 2024)

by Emily Mullin and Matt Reynolds

STAT and The Examination

Former FDA lawyers join tobacco industry in ‘epic’ fight against the agency (October 21, 2024)

by Kathryn Kranhold

Wall Street Journal

Ten years of payment disclosure does little to curtail corporate influence over doctors (July 23, 2024)

by Dylan Tokar

Biospace

Patient assistance programs: a source of real-world data? (July 8, 2024)

by Patience Asanga

BioSpace

FDA set date for Eli Lilly’s donanemab adcomm while pondering changes to format (May 7, 2024)

by Heather McKenzie

STAT News

Some nonprofit hospitals spend less on charity care than they receive in tax breaks, new analysis shows (full PDF) (March 26, 2024)

by Brittany Trang

The Hill

Florida scores drug import win — but many hurdles remain (January 6, 2024)

by Nathaniel Weixel

Forbes

How this startup is using 10 million patient records to reduce bias in healthcare A.I. (December 21, 2023)

by Katie Jennings

New York Times

Doctors wrestle with A.I. in patient care, citing lax oversight (October 30, 2023)

by Christina Jewett

Fierce Pharma podcast (Audio)

‘The Top Line’: A look at the FDA’s Aduhelm approval and the potential for regulatory bias (October 27, 2023)

Interview with Kevin Dunleavy

BioSpace

Upcoming NurOwn adcomm highlights regulatory role for patient advocates (September 25, 2023)

by Heather McKenzie

Politico

Future Pulse (September 7, 2023)

by Carmen Paun, Erin Schumaker, and Daniel Payne

Axios

1 in 3 HHS appointees leave for industry jobs, study finds (September 6, 2023)

by Jason Milliman

STAT News

How a ‘weighted lottery’ helped underserved patients get a scarce Covid drug (September 1, 2023)

by Usha Lee McFarling

Washington Post

How a renowned fertility doctor profits from an unproven supplement (July 30, 2023)

by Yeganeh Torbati

Politico

Who will get the new Alzheimer’s drug? (July 11, 2023)

by Katherine Ellen Foley and David Lim

MedPage Today

FDA appears to mostly follow its drug advisory committees’ advice (July 7, 2023)

by Joyce Frieden

Becker’s Hospital Review

The potential healthcare privacy risks of ChatGPT (July 7, 2023)

by Giles Bruce

Wall Street Journal

Some cancer patients must travel hundreds of miles for medication (June 12, 2023)

by Stephanie Armour

Spectrum News (Video)

Over 100 customers join Olaplex lawsuit, claim its products damaged hair (June 3, 2023)

by Renee Eng

BioSpace

Billy Dunn’s Prothena board position reignites ethical debate (May 23, 2023)

by Heather McKenzie

STAT

New mega-deal highlights Geisinger’s fall, and raises concerns about where Kaiser is going (May 1, 2023)

by Bob Herman

Modern Healthcare

Health systems turn to venture capital amid financial challenges (April 17, 2023)

by Gabriel Perna

Managed Healthcare Executive

Oncologist, dispense it thyself (November 11, 2022)

by Deborah Adams Kaplan

Renal & Urology News

Cyberattacks in health care are escalating (November 23, 2022)

by John Schieszer

Calling Bullsh!t Podcast (Audio)

FDA: Is there something rotten here? (October 26, 2022)

Interview with Ty Montague of co:collective

STAT

At Verily, a growing line of business builds on a revolving door to the FDA (October 4, 2022)

by Katie Palmer

PolitiFact

Why were the recent COVID-19 booster authorized before human trials were completed? (September 13, 2022)

by Andy Nguyen

Daily Beast

The new coronavirus wave is shutting schools all over again (December 16, 2021)

by Pilar Melendez

Nature

New FDA chief will face COVID woes and calls for drug-approval reform (November 12, 2021)

by Max Kozlov

Deep Background podcast (Audio)

Getting answers on vaccine boosters (September 22, 2021)

Interview with Noah Feldman

Daily Beast

The nation's largest teachers' union just backed a vaccine mandate. Schools are already in chaos (August 13, 2021)

by Pilar Melendez

Kaiser Health News

National Academies' report took pharma-friendly stance after millions in gifts from drugmakers (August 12, 2021)

by Christina Jewett

FiveThirtyEight

Still unsure about getting the COVID-19 vaccine? Start here (August 11, 2021)

by Kaleigh Rogers

The Intercept

UnitedHealthcare guided Yale's groundbreaking surprise billing story (August 10, 2021)

by Rose Adams

Daily Beast

Wacky Texas COVID rules push mom to home-school for second year in a row (August 9, 2021)

by Pilar Melendez

Daily Beast

Don't try to MacGyver a COVID-19 booster shot (July 20, 2021)

by Pilar Melendez

STAT

Too close for comfort: FDA shouldn't loosen conflict rules for its expert panels (July 19, 2021)

by Ed Silverman

Daily Beast

Full vaccine approval is coming. But is it too late? (July 17, 2021)

by Pilar Melendez

Washington Post

The pandemic rocked this small hospital in a mostly Black suburb. Now it's trying to grow (June 21, 2021)

by Rachel Chason

Fortune

The Spinal Tap: Device makers have funneled billions to orthopedic surgeons who use their products (June 17, 2021)

by Fred Schulte, Elizabeth Lucas, and Kaiser Health News

NPR All Things Considered

With coronavirus variants on the rise, vaccine companies and FDA pivot (February 10, 2021)

by Sydney Lupkin

Washington Post

The racist history that explains why some communities don't have enough ICU beds (September 16, 2020)

by George Aumoithe

Philadelphia Inquirer

Another COVID inequity: low-income and rural communities lack access to ICU beds, Penn study finds (August 5, 2020)

by Kasra Zarei

New York Times

'Like a horror movie': a small border hospital battles the coronavirus (August 4, 2020)

by Edgar Sandoval

Well + Good

Why 'transport to the nearest hospital' protocol doesn't work in a pandemic (August 4, 2020)

by Kara Jillian Brown

Politico

New rural hot spots are ICU bed deserts, study finds (August 3, 2020)

by Tucker Doherty

STAT

Nearly half of low-income communities have no ICU beds in their area (August 3, 2020)

by Juliet Isselbacher

STAT

A lottery like no other offers up a cutting-edge medicine -- with lives on the line (February 7, 2020)

by Andrew Joseph and Ed Silverman

Science

Investigation reveals widespread double dipping in NIH program to pay off school debt (November 21, 2019)

by Charles Piller

Becker's Hospital Review

Consolidation of physician practices linked to ACOs, study finds (November 8, 2019)

by Morgan Haefner

Fierce Healthcare

ACOs linked to consolidation of physician practices, study finds (November 5, 2019)

by Joanne Finnegan

Philadelphia Inquirer

Many Philly-area Doctors Earn Cash on the Side Consulting for Big Pharma. Does It Mean Anything for Patients? (October 21, 2019)

by Aubrey Whelan and Sarah Gantz

Proto Magazine

Saving Stark: Can the Embattled Reform Law Adapt to a Newer Model of Health Care? (October 7, 2019)

by Linda Teslar

BioPharma Dive

Does Disclosure of Pharma Payments Harm Patient Trust in Doctors? (September 23, 2019)

Q&A with Andrew Dunn

Medscape

Sunshine Act Report: Docs See Nothing Wrong with Taking Payments (August 27, 2019)

by Leigh Page

CMAJ News

The Downside of Transparent Payments: Public Distrust of the Entire Profession (May 7, 2019)

by Caroline Mercer

Chicago Tribune (Post-Tribune)

Drug Company Payments to Doctors May Influence Prescription Choices (April 16, 2019)

by Trudy Lieberman

Medscape

Sunshine Act May Reduce Patient Trust in Physicians (April 16, 2019)

by Kerry Dooley Young

STAT

A Database That Reveals Industry Payments to Doctors Also Causes Patient Mistrust (April 15, 2019)

by Ed Silverman

Medscape

Patients Pay More for Growth Hormone, Suffer Restrictions on Use (April 15, 2019)

by Tara Haelle

MD Magazine

Public Knowledge of Industry Payments Leads to Distrust Among Patients (April 12, 2019)

by Patrick Campbell

Wharton Radio: Knowledge@Wharton (Audio)

Why Congress Might Relax Physician Anti-Kickback Rules (March 12, 2019)

Interview with Dan Loney

STAT

What Financial Ties? Most Americans Were Unaware of Database Showing Pharma Payments to Docs (March 4, 2019)

by Ed Silverman

NPR

New Court Documents Reveal OxyContin Manufacturer's Marketing Tactics (February 2, 2019)

by Deborah Becker

STAT

Purdue Pharma Cemented Ties with Universities and Hospitals to Expand Opioid Sales, Documents Contend (January 16, 2019)

by Andrew Joseph

Associated Press

Spinal-cord Stimulators Help Some Patients, Injure Others, part of ICIJ international investigation into medical device safety (November 26, 2018)

by Mitch Weiss and Holbrook Mohr

STAT

In Public, Lawmakers Scold Drug Distributors. Come Campaign Season, They Accept Their Cash Willingly (October 12, 2018)

by Lev Facher

STAT

Questions About Funding and Purpose Loom Over a Foundation Congress Created to Help the FDA (October 9, 2018)

by Ike Swetlitz

Marketplace Public Radio (Audio)

Kickbacks or a Helpful Service? Here's Why Pharma is Under Fire (September 21, 2018)

by Mitchell Hartman

Science

Hidden Conflicts? An Investigation Finds a Pattern of After-the-Fact Compensation by Pharma to Those Advising the U.S. Government on Drug Approvals (July 6, 2018)

by Charles Piller

Observer

Philly Residents Drink Less Coke After Soda Tax—But Diet Sales Stay Flat (April 13, 2018)

by John Bonazzo

Reuters

Doctors who take pharmaceutical money use Twitter to hype drugs (September 11, 2017)

by Ronnie Cohen

Chicago Tribune

Are drug firms paying your doctor? (August 17, 2017)

by Lisa Schencker and Jennifer Smith Richards

Philadelphia Inquirer

Two-thirds of patients are seen by doctors who got industry money (March 16, 2017)

by Tom Avril

Fierce Healthcare

65% of patients see doctors who get paid by drug companies (March 8, 2017)

by Joanne Finnegan

Becker's Hospital Review

65% of patients see physicians who've accepted money from drug, device industry (March 7, 2017)

by Mackenzie Bean

Modern Healthcare

Among some physicians, a concentration of patients--and of industry dollars, too (March 6, 2017)

by Elizabeth Whitman

The Atlantic

Why Trump's conflicts of interest matter (January 3, 2017)

by Olga Khazan

Modern Healthcare

The FDA's revolving door raises ethical questions (September 27, 2016)

by Elizabeth Whitman

Healthcare Triage (Video)

Doctors, money, and conflicts of interest [transcript] (October 20, 2014)

by Aaron Carroll

Wall Street Journal

Not every conflict of interest produces the same vote on FDA panels (September 9, 2014)

by Ed Silverman

New York Times

Doctors' Magical Thinking About Conflicts of Interest (September 8, 2014)

by Aaron Carroll